Back to the RadioSpace™ home page
NewsDirect story topics:
Consumer, Business & General Interest
Current Events & Public Affairs
Entertainment & Sports
Health & Medicine
Positive Clinical-Trial Results Suggest that a New Treatment for Severe 'Osteoarthritis of the Knee' May Be on the Horizon
Ampio Pharmaceuticals ConsumerFeature
Fully produced report in:
MP3 format
Ogg
Vorbis format
QuickTime
(MPEG-4/AAC) format
Windows Media Audio
9.2 format
(60 seconds)
-- How Will You Use This Story? --
:60
READER SCRIPT
(DOES NOT FULLY MATCH AUDIO)
"OSTEOARTHRITIS OF THE KNEE"--OR "O-A-K"--IS A PROGRESSIVE DISEASE THAT'S CHARACTERIZED OFTEN BY GRADUAL DEGRADATION AND LOSS OF CARTILAGE, IN THE KNEE-JOINT. TODAY, PATIENTS WITH THE MOST-SEVERE FORM OF "O-A-K" HAVE FEW TREATMENT-OPTIONS--OTHER THAN "TOTAL KNEE ARTHROSCOPY". HOWEVER, THERE MAY BE A NEW OPTION, ON THE HORIZON--ACCORDING TO "AMPIO PHARMACEUTICALS": 21-MILLION AMERICANS ARE CURRENTLY DIAGNOSED WITH "O-A-K". AND, THE PREVALENCE IS EXPECTED TO INCREASE. THAT'S WHY THE COMPANY IS DEVELOPING AN INJECTABLE TREATMENT THAT'S BASED ON A FILTRATE OF "F-D-A"-APPROVED "HUMAN SERUM ALBUMIN". THE COMPANY IS PLEASED WITH THE RECENT CLINICAL-TRIAL RESULTS--WHERE OVER TWO-THOUSAND PATIENTS HAVE BEEN TREATED, WITH NO SERIOUS DRUG-RELATED COMPLICATIONS. AND, IT WILL CONTINUE TO PROVIDE PATIENTS WHO ARE SUFFERING WITH SEVERE "O-A-K" AN OPPORTUNITY TO REDUCE THEIR PAIN, IMPROVE THEIR KNEE-FUNCTION, AND ACHIEVE A BETTER OVERALL QUALITY-OF-LIFE. TO LEARN MORE, VISIT "AMPIO-PHARMA"-DOT-COM.
For more information regarding Consumer Radio Network programming--including a full listing of current ConsumerFeatures--click here.
